title: Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.
abstract: OBJECTIVE
  The purpose of the present study was to investigate clinicopathologic features of gastric cancer patients with only positive peritoneal cytology in the absence of overt peritoneal metastases, and which might distinguish patients with poorer prognosis.
  
  
  METHODS
  Between September 1994 and August 2006, clinicopathological features were retrospectively evaluated in 37 consecutive patients with gastric cancer who underwent a curative resection and had positive peritoneal cytology in the absence of overt peritoneal metastases. Survival including disease-free survival (DFS) and overall survival (OS), and recurrence patterns were analyzed according to clinicopathologic characteristics.
  
  
  RESULTS
  The median follow-up period was 16.1 months (range, 3-45 months). The median DFS and OS of patients after curative resection were 10 months (range, 1-33 months) and 15 months (range, 2-45 months), respectively. All patients had recurred, in 34 (92%) with peritoneal dissemination. The overall 1-, 2-, 3-, and 5-year survival rates for the 37 consecutive patients were 43.2%, 45.9%, 5.4%, and 0%, respectively. Multiple linear regression analysis revealed that Borrmann type IV was an independent predictor for poorer prognosis.
  
  
  CONCLUSIONS
  A Borrmann type IV carcinoma may be the candidates for intraperitoneal chemotherapy among advanced gastric cancer patients.
authors: Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea.
authors: Cheong Ah
authors: CA
authors: Oh
authors: Jae Moon
authors: JM
authors: Bae
authors: Seung Jong
authors: SJ
authors: Oh
authors: Min Gew
authors: MG
authors: Choi
authors: Jae Hyung
authors: JH
authors: Noh
authors: Tae Sung
authors: TS
authors: Sohn
authors: Sung
authors: S
authors: Kim
mesh_terms: D003581:Cytodiagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery; D009367:Neoplasm Staging; D010529:Peritoneal Cavity / Q000166:cytology*; D010533:Peritoneal Lavage; D010534:Peritoneal Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery; D015996:Survival Rate; D013997:Time Factors